Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114328913 | 11432891 | 3 | F | 2009 | 20160824 | 20150828 | 20160902 | EXP | DK-DKMA-ADR 23116892 | DK-BAXTER-2015BAX046446 | BAXTER | 53.54 | YR | F | Y | 0.00000 | 20160902 | CN | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114328913 | 11432891 | 1 | PS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 267550 | MG | U | U | 12142 | 1200 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | ||
| 114328913 | 11432891 | 2 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 267550 | MG | U | U | 12142 | 1200 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | ||
| 114328913 | 11432891 | 3 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 267550 | MG | U | U | 12142 | 1200 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | ||
| 114328913 | 11432891 | 4 | SS | Farmorubicin | EPIRUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 40132.5 | MG | U | U | 0 | 180 | MG | QD | |||
| 114328913 | 11432891 | 5 | SS | Farmorubicin | EPIRUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 40132.5 | MG | U | U | 0 | 180 | MG | QD | |||
| 114328913 | 11432891 | 6 | SS | Farmorubicin | EPIRUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | GIVEN OVER 15 MIN | 40132.5 | MG | U | U | 0 | 180 | MG | QD | |||
| 114328913 | 11432891 | 7 | SS | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | U | U | 0 | 200 | MG | |||||||
| 114328913 | 11432891 | 8 | SS | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | OVER 60 MINUTES | U | U | 0 | 150 | MG | ||||||
| 114328913 | 11432891 | 9 | SS | Tamoxifen | TAMOXIFEN | 1 | Unknown | Y | 0 | ||||||||||
| 114328913 | 11432891 | 10 | SS | FEMARA | LETROZOLE | 1 | Unknown | 0 | |||||||||||
| 114328913 | 11432891 | 11 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 17836.6666 | MG | 0 | 20 | MG | QID | ||||||
| 114328913 | 11432891 | 12 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 17836.6666 | MG | 0 | 20 | MG | QID | ||||||
| 114328913 | 11432891 | 13 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 17836.6666 | MG | 0 | 20 | MG | QID | ||||||
| 114328913 | 11432891 | 14 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 17836.6666 | MG | 0 | 20 | MG | QID | ||||||
| 114328913 | 11432891 | 15 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 17836.6666 | MG | 0 | 20 | MG | QID | ||||||
| 114328913 | 11432891 | 16 | C | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | OVER 2 MINUTES | 1757.75 | MG | 0 | 6 | MG | QD | |||||
| 114328913 | 11432891 | 17 | C | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | OVER 2 MINUTES | 1757.75 | MG | 0 | 6 | MG | QD | |||||
| 114328913 | 11432891 | 18 | C | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | OVER 2 MINUTES | 1757.75 | MG | 0 | 6 | MG | QD | |||||
| 114328913 | 11432891 | 19 | C | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | OVER 2 MINUTES | 1757.75 | MG | 0 | 6 | MG | QD | |||||
| 114328913 | 11432891 | 20 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 3567.33333 | MG | 0 | 8 | MG | TABLET | BID | |||||
| 114328913 | 11432891 | 21 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 3567.33333 | MG | 0 | 8 | MG | TABLET | BID | |||||
| 114328913 | 11432891 | 22 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 3567.33333 | MG | 0 | 8 | MG | TABLET | BID | |||||
| 114328913 | 11432891 | 23 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 3567.33333 | MG | 0 | 8 | MG | TABLET | BID | |||||
| 114328913 | 11432891 | 24 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 3567.33333 | MG | 0 | 8 | MG | TABLET | BID | |||||
| 114328913 | 11432891 | 25 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 11147.9166 | MG | 0 | 50 | MG | TABLET | QD | |||||
| 114328913 | 11432891 | 26 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 11147.9166 | MG | 0 | 50 | MG | TABLET | QD | |||||
| 114328913 | 11432891 | 27 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 11147.9166 | MG | 0 | 50 | MG | TABLET | QD | |||||
| 114328913 | 11432891 | 28 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 11147.9166 | MG | 0 | 50 | MG | TABLET | QD | |||||
| 114328913 | 11432891 | 29 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 11147.9166 | MG | 0 | 50 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114328913 | 11432891 | 1 | Breast cancer |
| 114328913 | 11432891 | 4 | Breast cancer |
| 114328913 | 11432891 | 7 | Breast cancer |
| 114328913 | 11432891 | 9 | Breast cancer |
| 114328913 | 11432891 | 10 | Breast cancer |
| 114328913 | 11432891 | 11 | Product used for unknown indication |
| 114328913 | 11432891 | 16 | Product used for unknown indication |
| 114328913 | 11432891 | 20 | Product used for unknown indication |
| 114328913 | 11432891 | 25 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114328913 | 11432891 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114328913 | 11432891 | Cognitive disorder | |
| 114328913 | 11432891 | Constipation | |
| 114328913 | 11432891 | Contusion | |
| 114328913 | 11432891 | Decreased activity | |
| 114328913 | 11432891 | Laceration | |
| 114328913 | 11432891 | Lymphoedema | |
| 114328913 | 11432891 | Memory impairment | |
| 114328913 | 11432891 | Muscle spasms | |
| 114328913 | 11432891 | Onychomadesis | |
| 114328913 | 11432891 | Premature menopause | |
| 114328913 | 11432891 | Road traffic accident | |
| 114328913 | 11432891 | Sensory disturbance | |
| 114328913 | 11432891 | Skin exfoliation | |
| 114328913 | 11432891 | Stress | |
| 114328913 | 11432891 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114328913 | 11432891 | 1 | 20090812 | 0 | ||
| 114328913 | 11432891 | 2 | 20090902 | 0 | ||
| 114328913 | 11432891 | 3 | 20090930 | 0 | ||
| 114328913 | 11432891 | 4 | 20090812 | 0 | ||
| 114328913 | 11432891 | 5 | 20090902 | 0 | ||
| 114328913 | 11432891 | 6 | 20090930 | 0 | ||
| 114328913 | 11432891 | 7 | 20091021 | 20091113 | 0 | |
| 114328913 | 11432891 | 8 | 20091120 | 20091210 | 0 | |
| 114328913 | 11432891 | 10 | 20130918 | 0 | ||
| 114328913 | 11432891 | 11 | 20090812 | 0 | ||
| 114328913 | 11432891 | 12 | 20090902 | 0 | ||
| 114328913 | 11432891 | 13 | 20090930 | 0 | ||
| 114328913 | 11432891 | 14 | 20091021 | 0 | ||
| 114328913 | 11432891 | 15 | 20091210 | 0 | ||
| 114328913 | 11432891 | 16 | 20091021 | 0 | ||
| 114328913 | 11432891 | 17 | 20091113 | 0 | ||
| 114328913 | 11432891 | 18 | 20091120 | 0 | ||
| 114328913 | 11432891 | 19 | 20091210 | 0 | ||
| 114328913 | 11432891 | 20 | 20090812 | 0 | ||
| 114328913 | 11432891 | 21 | 20090902 | 0 | ||
| 114328913 | 11432891 | 22 | 20090930 | 0 | ||
| 114328913 | 11432891 | 23 | 20091021 | 0 | ||
| 114328913 | 11432891 | 24 | 20091210 | 0 | ||
| 114328913 | 11432891 | 25 | 20090812 | 0 | ||
| 114328913 | 11432891 | 26 | 20090902 | 0 | ||
| 114328913 | 11432891 | 27 | 20090930 | 0 | ||
| 114328913 | 11432891 | 28 | 20091021 | 0 | ||
| 114328913 | 11432891 | 29 | 20091210 | 0 |